SS
SLS icon

Sunbelt Securities’s SELLAS Life Sciences SLS Stock Holding History

Sunbelt Securities’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67K Buy
+395
New +$1.77K ﹤0.01% 1973

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Sunbelt Securities's SLS Position: Q1 2026 in Review

Sunbelt Securities opened a new position in SELLAS Life Sciences (SLS) in Q1 2026: 395 shares worth $1.67K. The stake represents ﹤0.01% of the portfolio and ranks #1973 among its holdings.

160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Sunbelt Securities held 395 shares of SELLAS Life Sciences worth $1.67K as of Q1 2026.
  • SELLAS Life Sciences was a new Sunbelt Securities position in Q1 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1973 holding.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.